The JAK3 inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline ( CAS 202475-60-3 , JANEX-1 , WHI-P131 ) prevented the rejection of islet allografts in mice with a normal JAK3 expression status .